Archives

by in
Entry Author Date Location
RNA Therapeutics Are Coming of Age 02/08/13 San Diego
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug 02/04/13 Boston
East Coast Life Sciences Roundup: Aveo, Mayo Clinic, GI Dynamics, More 01/18/13 Boston
Alnylam, Lawsuit Settled, Announces $125 Million Stock Offering 01/15/13 Boston
Alnylam, Tekmira Look Ahead After RNAi Divorce 11/14/12 Boston
Alnylam to Pay Tekmira $65M to Settle RNAi Delivery Dispute 11/12/12 Boston
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Alnylam Gets $22.5M From Genzyme for Asia Rights to Amyloidosis Drug 10/22/12 Boston
San Diego Life Sciences Roundup: Regulus IPO, Fate Funding, & More 08/23/12 San Diego
Regulus Therapeutics Files for IPO as ‘Emerging Growth’ Company 08/20/12 San Diego
Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names 08/13/12 National
Alnylam, Galenea, Gen9, & More from the Boston Life Sciences Roundup 07/20/12 Boston
Alnylam Stock Climbs on Positive Early Trial for Amyloidosis 07/16/12 Boston
Join Us for BIO Tweetchat at 12:30 pm ET with John Maraganore 06/15/12 National
What Are the Hottest Targets in Biotech Today? 04/23/12 National
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals 03/12/12 National
Reinventing Biotech: Meet Corey Goodman, Kevin Starr & More April 3 02/23/12 Seattle
Alnylam Cuts One-Third of Workforce, To Save Cash for RNAi Clinical Plans 01/19/12 Boston
Join Kevin Starr, Corey Goodman, Carl Weissman & More in Seattle April 3 01/19/12 Seattle
Biology 101 01/18/12 Boston
Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers 01/06/12 Boston
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Alnylam Racing to Prove RNAi Works, For a Disease You’ve Never Heard Of 12/13/11 Boston
Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News 11/04/11 Boston
Alnylam and Glaxo Partner on RNAi for Vaccine Production 11/01/11 Boston
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News 10/07/11 Boston
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News 10/06/11 Seattle
Tweetchat on RNA Interference Upstages iPhone (Not Really, but It Was Still Fun) 10/05/11 National
Join Us at 1 pm Eastern/10 am Pacific for RNAi “Tweetchat” with Alnylam’s John Maraganore 10/04/11 National
Page 2 of 8 « previous page · next page »